These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 21887536)
1. Automated striatal uptake analysis of ¹⁸F-FDOPA PET images applied to Parkinson's disease patients. Chang IC; Lue KH; Hsieh HJ; Liu SH; Kao CH Ann Nucl Med; 2011 Dec; 25(10):796-803. PubMed ID: 21887536 [TBL] [Abstract][Full Text] [Related]
2. Utility of intrastriatal ratios of FDOPA to differentiate idiopathic Parkinson's disease from atypical parkinsonian disorders. Jaimini A; Tripathi M; D'Souza MM; Panwar P; Sharma R; Mehta S; Pandey S; Saw S; Singh D; Solanki Y; Mishra AK; Mondal A Nucl Med Commun; 2013 May; 34(5):426-31. PubMed ID: 23458855 [TBL] [Abstract][Full Text] [Related]
3. A simple algorithm for subregional striatal uptake analysis with partial volume correction in dopaminergic PET imaging. Lue KH; Lin HH; Kao CH; Hsieh HJ; Liu SH; Chuang KS Ann Nucl Med; 2014 Jan; 28(1):33-41. PubMed ID: 24135967 [TBL] [Abstract][Full Text] [Related]
9. [(18)F]FDOPA and [(18)F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease. Rinne OJ; Nurmi E; Ruottinen HM; Bergman J; Eskola O; Solin O Synapse; 2001 Jun; 40(3):193-200. PubMed ID: 11304757 [TBL] [Abstract][Full Text] [Related]
10. Striatal dopa and glucose metabolism in PD patients with freezing of gait. Bartels AL; de Jong BM; Giladi N; Schaafsma JD; Maguire RP; Veenma L; Pruim J; Balash Y; Youdim MB; Leenders KL Mov Disord; 2006 Sep; 21(9):1326-32. PubMed ID: 16721756 [TBL] [Abstract][Full Text] [Related]
11. Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson's disease patients. Huang WS; Chiang YH; Lin JC; Chou YH; Cheng CY; Liu RS J Nucl Med; 2003 Jul; 44(7):999-1005. PubMed ID: 12843212 [TBL] [Abstract][Full Text] [Related]
12. Comparison of dopamine turnover, dopamine influx constant and activity ratio of striatum and occipital brain with ¹⁸F-dopa brain PET in normal controls and patients with Parkinson's disease. Oehme L; Perick M; Beuthien-Baumann B; Wolz M; Storch A; Löhle M; Herting B; Langner J; van den Hoff J; Reichmann H; Kotzerke J Eur J Nucl Med Mol Imaging; 2011 Aug; 38(8):1550-9. PubMed ID: 21553090 [TBL] [Abstract][Full Text] [Related]
13. Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies. Wile DJ; Agarwal PA; Schulzer M; Mak E; Dinelle K; Shahinfard E; Vafai N; Hasegawa K; Zhang J; McKenzie J; Neilson N; Strongosky A; Uitti RJ; Guttman M; Zabetian CP; Ding YS; Adam M; Aasly J; Wszolek ZK; Farrer M; Sossi V; Stoessl AJ Lancet Neurol; 2017 May; 16(5):351-359. PubMed ID: 28336296 [TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of striatal FDOPA uptake in Parkinson's disease: ratio method versus graphical approach. Dhawan V; Ma Y; Pillai V; Spetsieris P; Chaly T; Belakhlef A; Margouleff C; Eidelberg D J Nucl Med; 2002 Oct; 43(10):1324-30. PubMed ID: 12368370 [TBL] [Abstract][Full Text] [Related]
15. A revisit to quantitative PET with Akamatsu G; Ohnishi A; Aita K; Nishida H; Ikari Y; Sasaki M; Kohara N; Senda M Ann Nucl Med; 2017 Feb; 31(2):163-171. PubMed ID: 27914043 [TBL] [Abstract][Full Text] [Related]
16. Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls. Jokinen P; Helenius H; Rauhala E; Brück A; Eskola O; Rinne JO J Nucl Med; 2009 Jun; 50(6):893-9. PubMed ID: 19443601 [TBL] [Abstract][Full Text] [Related]